Trial Profile
A prospective pressure flow study of dutasteride add-on therapy in patients with benign prostatic enlargement: Urodynamic effects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 12 Dec 2015 New trial record